Skip to content
healthcare.dev

Dapagliflozin

NDC 42571-318, Dapagliflozin, tablet, from Micro Labs Limited.

Product NDC
42571-318
Status
Listed
Labeler
Micro Labs Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211467
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42571-318 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN10 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
42571-318-10425710318101000 TABLET in 1 BOTTLE (42571-318-10)
42571-318-304257103183030 TABLET in 1 BOTTLE (42571-318-30)
42571-318-904257103189090 TABLET in 1 BOTTLE (42571-318-90)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5dc0e9df-3b45-4469-93fe-3d2eddbfe2b7

Use it

Look up 42571-318 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42571-318 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42571-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.